ICUI — ICU Medical, Inc. stock price, charts and financials

QT71ICU Medical, Inc.

ICU Medical, Inc. (NASDAQ: ICUI) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
185.04
+0.48+0.26%
ICUIQT71ICU Medical, Inc.·NASDAQ
185.04+0.26%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E153.80EPS (ttm)1.20Insider Own18.76%Shs Outstand24.99MPerf Week9.52%
Market Cap4.61BForward P/E19.83EPS next Y9.31Insider Trans-0.15%Shs Float24.50MPerf Month17.91%
Enterprise Value5.55BPEG0.01EPS next Q-Inst Own-Short Float7.48%Perf Quarter49.96%
Income29.98MP/S2.14EPS this Y341.36%Inst Trans-Short Ratio6.10Perf Half Y23.34%
Sales2.16BP/B2.14EPS next Y13.97%ROA0.76%Short Interest1.83MPerf YTD29.36%
Book/sh-P/C16.76EPS next 5Y7.95%ROE1.41%52W High193.36 -4.30%Perf Year45.45%
Cash/sh-P/FCF25.56EPS past 3/5Y- -62.60%ROIC-21.74%52W Low107.28 72.49%Perf 3Y7.62%
Dividend Est.-EV/EBITDA18.63Sales past 3/5Y-0.74% 11.90%Gross Margin37.56%Volatility3.69% 3.17%Perf 5Y-9.21%
Dividend TTM-EV/Sales2.57EPS Y/Y TTM138.30%Oper. Margin5.04%ATR (14)6.69Perf 10Y59.03%
Dividend Ex-Date-Quick Ratio1.21Sales Y/Y TTM-9.49%Profit Margin1.39%RSI (14)73.37Recom2.00
Dividend Gr. 3/5Y-Current Ratio2.43EPS Q/Q14.53%SMA2013.02%Beta0.75Target Price186.40
Payout0.00%Debt/Eq0.57Sales Q/Q-12.40%SMA5022.05%Rel Volume2.87Prev Close184.56
Employees13,000LT Debt/Eq0.64EarningsAug 06SMA20031.29%Avg Volume324.54KPrice185.04
IPO DateMar 31, 1992Option/ShortYes / YesEPS/Sales Surpr.12.42% 0.98%Net Debt/EBITDA3.13Volume931,222Change0.26%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-07-26ReiteratedNeedhamBuy$165$187
Aug-07-26ReiteratedBTIG$170$200
Aug-07-26ReiteratedRaymond JamesStrong Buy$97$200
Jul-21-26ReiteratedKeybancOverweight$164$182
Jun-15-26InitiatedBTIGBuy$170
May-27-26UpgradeNeedhamHoldBuy$165
Apr-27-26ReiteratedKeybancOverweight$180$164
Apr-17-26ReiteratedPiper SandlerOverweight$178$163
Feb-20-26ReiteratedKeybancOverweight$173$180
Feb-20-26ReiteratedPiper SandlerOverweight$153$178
Latest News
Aug-07-26
Aug-06-26
Aug-06-2611:04PM
Jul-23-26
Jul-21-26
Jul-09-26
Jul-08-26
Jun-15-26
Company

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,1592,2302,382
Cost of Goods Sold Incl. D&A1,3481,4101,557
Gross Profit811820825
Selling, General and Administrative Excl. Other616625639
Research and Development868789
Other Operating Expense0154
Operating Income10910743
Interest Expense84105107
Unusual Expense
Non-Operating Income (Expense)-302-2
Net Income Before Taxes-43-66
Income Taxes-32252
Consolidated Net Income301-118
Net Income From Continuing Operations271-118
Net Income301-118
EPS (Recurring)1.200.03-4.83
EPS (Basic, Before Extraordinaries)1.200.03-4.83
EPS (Diluted)1.180.03-4.83
EBITDA29832743
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio156.824,852.72
Price To Sales Ratio2.141.601.56
Gross Margin37.5636.7734.63
Operating Margin5.054.801.81
Net Margin1.390.04-4.95
Shares Outstanding252524
Market Capitalization4,6263,5673,724
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$196.03$171.18$146.33$121.48$96.63 Close Price0.00M0.66M1.31M1.97M2.63MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Woolson DanielPresidentMay 22 '26Sale132.212,123280,68522,479May 22
Sanzone Virginia RuthVP, General CounselMay 14 '26Sale124.082,447303,62419,460May 15
Hoffmeister David FDirectorMay 13 '26Option Exercise0.001,25406,004May 13
KENNEDY KOLLEEN TDirectorMay 13 '26Option Exercise0.001,25404,539May 13
Greenberg David C.DirectorMay 13 '26Option Exercise0.001,25409,214May 13
Hernandez LaurieDirectorMay 13 '26Option Exercise0.001,25404,862May 13
Abbey DonaldDirectorMay 13 '26Option Exercise0.001,25406,004May 13
FINNEY ELISHA WDirectorMay 13 '26Option Exercise0.001,25405,249May 13
Greenberg David C.DirectorMay 12 '26Sale122.912,424297,9347,960May 13
Greenberg David C.DirectorMay 12 '26Option Exercise101.062,424244,96910,384May 13
Bonnell Brian MichaelChief Financial OfficerMar 15 '26Option Exercise0.0014,648076,097Mar 16
Voigtlander Christian B.Chief Operating OfficerMar 15 '26Option Exercise0.0014,648051,154Mar 16
Woolson DanielVP, GM-Infusion CapitalMar 15 '26Option Exercise0.002,924025,897Mar 16
Sousa BenChief Information OfficerMar 15 '26Option Exercise0.001,30006,044Mar 16
Sanzone Virginia RuthVP, General CounselMar 15 '26Option Exercise0.007,324024,330Mar 16
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.